login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Suven Seeks Permission for Trials of New Drug
'Treatment for Alzheimer's disease and Schizophrenia is an unmet medical need and Suven's primary focus is to discover drugs that address significant unmet medical needs,' said a statement by the firm.
Suven is a Hyderabad-based life sciences company, which is involved in contract research and manufacturing services, drug discovery and development support services and collaborative research partner with global pharma majors.
Suven's research focuses on developing treatments for Central Nervous System (CNS) disorders through novel mechanisms using small-molecule medicinal chemistry approaches.
Source-IANS
JAY/M
|
|
More News on: Drug Toxicity, Clinical Trials - Different Phases of the trial , Signature Drug Toxicity
 Comment & Contribute
|
Medwonders Health Network
- Health News Index
- News Quick Links
| News Categories: |
| » | Mystery of 'Disappearing' Tweets Solved |
| » | 'Slut Walks' Attract Thousands in Brazil |
| » | Enthusiasm for Tattoos High Among Women |
| » | Individuals' Brains 'Tick Together' If They Have Strong Emotions |
| » | Keeping Emotions in Check and Being Resilient Helps to Remain Satisfied With Life |
| More Life Style News | |
|
